Ascom and Dräger announce partnership to deliver clinical alarm management solutions to healthcare providers
Ascom Holding AG / Ascom and Dräger announce partnership to deliver clinical alarm management solutions to healthcare providers . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Ascom partners with Dräger, a leading producer of medical and safety technology, to integrate the Ascom industry leading Ascom Unite clinical messaging platform and Dräger's patient monitoring systems. The joint solution provides location agnostic alerts combining outcome quality and operational efficiency with reporting and analytics.
BAAR, Switzerland, Aug. 25, 2017 (GLOBE NEWSWIRE) -- The Ascom Unite system extends the reach of patient status alarms generated by Dräger vital signs monitors and therapy devices integrated with the monitors. Ascom Unite distributes clinical alert notifications along with critical data and related contextual information to mobile devices carried by care team members, who might not be at the sides of their patients requiring assistance.
Ascom Unite directs alerts to only those responsible for the care of the patients requiring clinical intervention, leaving other nearby care providers to work without interruption. Reducing the number of audible alerts and pages broadcast for all to hear helps alleviate alarm fatigue that is generally experienced by care providers in high-volume, high acuity care areas. Ascom Unite's intelligent alarm filtering further minimizes the care providers' exposure to low-priority, routine alerts that might ordinarily contribute to workflow bottlenecks and inefficiencies. Patients benefit from quicker responses and more focused care providers as well as quieter healing environments. The joint solution will be made available on markets served by Ascom (SWX:ASCN.SW) and Dräger subject to necessary approvals.
"The new partnership with Ascom is an exciting and important step in making enhanced alarm management solutions available to hospitals worldwide," says Steffen Protsch, Senior Vice President of Medical Systems at Dräger. "We are pleased to further help the users of Dräger monitors and therapy devices improve their workflow and patient safety."
André Neu, Senior Vice President Platform Solutions at Ascom states: "Enabling mobile access to patient monitoring events leverages and extends the reach of a hospital's patient monitoring system investment. By partnering with Dräger, Ascom will be able to boost workflow effectiveness by helping mobile caregivers avoid unnecessary work interruptions and support faster decision making."
Ascom Unite records information associated with each patient event, including the priority level of an alert, patient data and waveform images sent to the mobile device from the monitor, the start time of the alarm received from the monitor, and the time of the caregiver's response. Periodic review of these records can be useful in evaluating alarm response procedures and in demonstrating the effectiveness of a response strategy.
Ascom is a global solutions provider focused on healthcare ICT and mobile workflow solutions. The vision of Ascom is to close digital information gaps allowing for the best possible decisions - anytime and anywhere. Ascom's mission is to provide mission-critical, real-time solutions for highly mobile, ad hoc, and time-sensitive environments. Ascom uses its unique product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide truly smooth, complete and efficient workflows for healthcare as well as for industry and retail sectors.
Ascom is headquartered in Baar (Switzerland), has subsidiaries in 15 countries and employs around 1,200 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.
ABOUT DRÄGER. Technology for Life®
Dräger (Drägerwerk AG & Co. KGaA) is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of more than EUR 2.5 billion in 2016. The Dräger Group is currently present in over 190 countries and has more than 13,000 employees worldwide. Visit www.draeger.com for more information.
Contact: Dan Allen, Product Marketing
Phone: +1 (919) 234-2527
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ascom Holding AG via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer23.1.2018 21:11 | Pressemelding
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies-the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP)-have updated their 2013 evidence-based guideline. Published today in early online release, the "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors," continues to set standards for the molecular analysis of lung cancers for test results that effectively guide targeted therapy and treatment. Targeted cancer therapies are drugs or other treatments that block the spread of cancer by interfering with specific molec
CashBet Seeks $40 Million for World's Only Complete Crypto-Ready Mobile iGaming Platform23.1.2018 16:31 | Pressemelding
Gaming and cryptocurrency industry leaders develop blockchain-based iGaming platform improving trust, speed, access, costs, and content availability OAKLAND, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Leading mobile-first iGaming platform provider CashBet (https://coin.cashbet.com/) today announced it seeks to raise $40 million through an Initial Coin Offering (ICO) to develop the world's first complete crypto-ready mobile iGaming platform. Interactive gaming, which includes real money, social, skill-based, esports and sports betting, hit $91 billion in 2016, led by mobile gaming. Despite strong growth, current iGaming operations continue to face three major issues: trust, speed, and cost. CashBet is the first and only vertically integrated iGaming solution to leverage blockchain technology for transparent operations, increased speed, and lower transaction fees. The CashBet Coin will be available in pre-sale starting January 24, 2018 at 5:00 p.m. GMT, with a 20 percent discount offered.
BrandSafway Announces Acquisition of Venko Groep BV23.1.2018 16:30 | Pressemelding
Combined customers to benefit from broader range of services and greater depth of expertise KENNESAW, GA, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has acquired Venko Groep BV, a portfolio company of Mentha Capital, effective January 1, 2018. Moving forward, the company will operate as Venko, A BrandSafway Company and become a part of Brand Energy & Infrastructure Services (Brand) in Europe. "We're excited to announce the closing of the acquisition of Venko," said Dave Witsken, President of Energy and Industrial for BrandSafway. "Venko is a leading offshore coatings maintenance provider for platforms in Europe. By leveraging the highly specialized knowledge and capabilities of Venko, we will be able to provide expanded coatings services to Brand's European customers. At the same time, with our support, Venko will now be able to offer their customers a broader inventory of access equipment and additional industrial services, such as insulation an
Mitratech's TeamConnect Rated Most Widely Used Matter Management System in HBR Consulting's Annual Law Department Survey23.1.2018 15:00 | Pressemelding
HBR's Annual Survey further validates TeamConnect's market leadership AUSTIN, Texas, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Mitratech, the leading provider of legal, compliance, and risk management software solutions announced that TeamConnect, the market-leading ELM (enterprise legal management) platform, was rated the most widely used matter management system and the second most widely used e-Billing system in the 2017 HBR Consulting (HBR) Law Department Survey. HBR's Law Department Survey released this month rated Mitratech's TeamConnect as the most widely used system for matter management out of the 13 systems included in the survey. All told, Mitratech's ELM solutions accounted for more than a third of the matter management user base. TeamConnect also was rated for the third year in a row as the second most widely used e-Billing system, continuing a years-long trend of customers shifting to Mitratech's integrated ELM platform from other point solutions. Customer satisfaction continues
Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 201823.1.2018 14:53 | Pressemelding
SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will unveil data supporting use of its cost-effective, humanized drug target models at the Tumor Models Conference in San Francisco tomorrow, Wednesday, January 24th, 2018. Humanized research tools are crucial to the development of target-specific immunotherapies like pembrolizumab and ipilimumab. To help improve research in this burgeoning field, CrownBio has developed a humanized platform that informs the preclinical pharmacology of targeted immunotherapies, including solutions for PD-1, PD-L1, OX40, and CD3E. Constituent models feature fully functional murine immunity with humanized drug targets that can be used in conjunction with syngeneic tumor cell lines engineered to expr
Music Legend Joey Fatone Will Be Celebrity Grand Marshal Of First Ever 15th Annual World's Shortest St. Patrick's Day Parade In Hot Springs, Arkansas23.1.2018 13:56 | Pressemelding
HOT SPRINGS NATIONAL PARK, Ark., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Music legend Joey Fatone, who soared to worldwide fame as a member of boy-band *NSYNC, will be celebrity grand marshal of the First Ever 15th Annual World's Shortest St. Patrick's Day Parade in downtown Hot Springs March 17, 2018, reports Hot Springs Convention & Visitors Bureau. He'll round out a quartet of celebrities who will be part of the quirky parade, which annually draws throngs to world-famous Bridge Street, the shortest street in the world in everyday use - 98 feet long. Jon Heder, who became famous as Napoleon Dynamite, will be the parade's official starter. The 2018 parade will begin at 7:30 p.m., an hour later than previous years. The start time was changed to allow Oaklawn racing fans plenty of time to enjoy the live racing including The Rebel Stakes at Oaklawn Park, and still get downtown for the start of the parade. Morris Day and the Time will perform a free concert at the conclusion of the parade. On F
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom